The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / New EPA Rule May Hinder Health Research

New EPA Rule May Hinder Health Research

January 29, 2019 • By Linda Carroll

  • Tweet
  • Email
Print-Friendly Version / Save PDF

(Reuters Health)—A new rule proposed by the U.S. Environmental Protection Agency (EPA) may make it almost impossible to uncover hazards such as dirty air, polluted water and environmental toxins, researchers say.

You Might Also Like
  • Department of Health and Human Services’ Final Rule Expands HIPAA Obligations, Violation Penalties
  • Trump Administration Rule Would Let More People Drop Obamacare
  • U.S. Government Proposes Rule Overhauling Drug Industry Rebate System

The rule mandates that all underlying data from studies be made available to any and all researchers in the interests of transparency. But while transparency is generally a laudable goal, the rule may be used to throw out older studies for which data is no longer available and newer studies with data that can’t be shared because of patient privacy issues, says Renee Salas, MD, MPH, MS, the lead author on an opinion piece published in Annals of Internal Medicine, Jan. 28.1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Salas, an emergency medicine physician at the Massachusetts General Hospital and a researcher with the Harvard Global Health Institute, Boston, tells Reuters Health the new rule would be “turning the existing system on its head.”

“Instead of being automatically considered, a study that uses protected health information or human subjects cannot be considered except on a case by case basis,” Dr. Salas says.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

If the rule is passed, the data used in studies must be made available to anyone who wants to “independently validate the research,” Salas says. “But to do that would erode patient confidentiality, which we as researchers have a mandate to protect.”

Many studies, for example, don’t include participants’ names, but do include information about where they liv—which is necessary if a researcher is trying to discern possible health hazards due to pollution. If the data is made available with the patient addresses, that would violate confidentiality. But if researchers don’t know how far people live from a potential source of pollution, they won’t be able to connect symptoms with the environmental hazard.

The researchers point to the example of the Harvard Six Cities Study, which determined that fine particle pollution in the air was strongly and consistently linked to an increased risk of death. That study “was fundamental to the EPA’s implementation of the Clean Air Act, and the evidence is clear: the stringent air regulations improved health and saved lives,” Salas and her colleagues wrote. “Although the Six Cities Study has been heralded as transparent, high quality science, the proposed rule would have excluded it from the EPA’s consideration.”

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Beyond that, Dr. Salas says, many of the EPA’s regulatory decisions have been based on decades-old studies for which the raw data are no longer available.

Pages: 1 2 | Single Page

Filed Under: Professional Topics Tagged With: public health, Research, U.S. Environmental Protection Agency (EPA)

You Might Also Like:
  • Department of Health and Human Services’ Final Rule Expands HIPAA Obligations, Violation Penalties
  • Trump Administration Rule Would Let More People Drop Obamacare
  • U.S. Government Proposes Rule Overhauling Drug Industry Rebate System
  • Trump Administration Issues Final Rule on Stricter Obamacare Enrollment

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.